Citation Impact
Citing Papers
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Role of target geometry in phagocytosis
2006 Standout
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Identification of interferon-stimulated genes that attenuate Ebola virus infection
2020 StandoutNobel
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Relative resistance of HIV-1 founder viruses to control by interferon-alpha
2013
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms
2014
Persistent immune activation in chronic HIV infection
2013
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
2016 Standout
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
The World report on ageing and health: a policy framework for healthy ageing
2015 Standout
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
2008 Standout
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Hepatitis C virus genotype 3: a genotype that is not ‘easy-to-treat’
2014
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Receptors and routes of dengue virus entry into the host cells
2015
Inflammatory Co-morbidities in HIV+ Individuals: Learning Lessons from Healthy Ageing
2014
Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts
2018
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Transient receptor potential channels: targeting pain at the source
2008 StandoutNobel
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study
2015 StandoutNobel
Coreceptors and HIV-1 Pathogenesis
2010
Microbial translocation, immune activation, and HIV disease
2012
Initiation of Antiretroviral Therapy at CD4 Cell Counts ≥350 Cells/mm3 Does Not Increase Incidence or Risk of Peripheral Neuropathy, Anemia, or Renal Insufficiency
2008
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Impact of Suppression of Viral Replication by Highly Active Antiretroviral Therapy on Immune Function and Phenotype in Chronic HIV-1 Infection
2002
HIV: Cell Binding and Entry
2012
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) in HIV Patients with Culture Confirmed Pulmonary Tuberculosis in India and the Potential Role of IL-6 in Prediction
2013
Relationship between T Cell Activation and CD4 + T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy
2007
Highly multiparametric analysis by mass cytometry
2010
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials
2011
MX2 is an interferon-induced inhibitor of HIV-1 infection
2013 StandoutNatureNobel
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection
2013 Nature
HIV-1 and interferons: who's interfering with whom?
2015
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
2011
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
2011
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Host-directed therapies for bacterial and viral infections
2017
Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients
2011
Self-amplifying RNA vaccines for infectious diseases
2020
The Hallmarks of Aging
2013 Standout
Identification of Interferon-Stimulated Genes with Antiretroviral Activity
2016 StandoutNobel
LPS-Binding Protein and IL-6 Mark Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome in HIV Patients
2013
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
2014
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
2010
SARS-CoV-2 vaccines in development
2020 StandoutNature
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Anti-CD4-targeted Gold Nanoparticles Induce Specific Contrast Enhancement of Peripheral Lymph Nodes in X-ray Computed Tomography of Live Mice
2010
Human microsporidial infections
1994 Standout
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
2015
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
HIV Infection, Inflammation, Immunosenescence, and Aging
2010
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy
2008
IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy
2006 StandoutNobel
Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism
2013
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
IL-7 Abrogates Suppressive Activity of Human CD4+CD25+FOXP3+ Regulatory T Cells and Allows Expansion of Alloreactive and Autoreactive T Cells
2012
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution
2012
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Scanning the Potential Energy Surface for Synthesis of Dendrimer-Wrapped Gold Clusters: Design Rules for True Single-Molecule Nanostructures
2012 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Characterization of the Alpha Interferon-Induced Postentry Block to HIV-1 Infection in Primary Human Macrophages and T Cells
2010
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
T-cell quality in memory and protection: implications for vaccine design
2008
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Emerging Concepts in the Immunopathogenesis of AIDS
2008
Host and Viral Determinants of Mx2 Antiretroviral Activity
2014
Multiple effects on Clostridium perfringens binding, uptake and trafficking to lysosomes by inhibitors of macrophage phagocytosis receptors
2003
Effect of Nanoparticles on the Cell Life Cycle
2011
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
2004
Works of David M. Asmuth being referenced
Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection
2012
Nine‐color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms
2008
Host Gene Expression Changes Correlating With Anti–HIV-1 Effects in Human Subjects After Treatment With Peginterferon Alfa-2a
2012
Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals
2001
Effect of Baseline- and Treatment-Related Factors on Immunologic Recovery After Initiation of Antiretroviral Therapy in HIV-1-Positive Subjects
2006
Clinical Features of Microsporidiosis in Patients with AIDS
1994
Cell cycle kinetic dysregulation in HIV‐infected normal lymphocytes
2005
`Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses
2000
Comparative Cell‐Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV‐1 Clade BgagVaccine Prime‐Boost Regimens
2009
Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384
2009
Elevated Interleukin 8 and T-Helper 1 and T-Helper 17 Cytokine Levels Prior to Antiretroviral Therapy in Participants Who Developed Immune Reconstitution Inflammatory Syndrome During ACTG A5164
2012
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA
2016
Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa‐2a in HIV‐1–Monoinfected Participants: A Phase II Clinical Trial
2010
Molecular Characterization of Stool Microbiota in HIV-Infected Subjects by Panbacterial and Order-Level 16S Ribosomal DNA (rDNA) Quantification and Correlations With Immune Activation
2011
Effects of Clostridium perfringens Recombinant and Crude Phospholipase C and -toxin on Rabbit Hemodynamic Parameters
1995
Quantitative 3D Video Microscopy of HIV Transfer Across T Cell Virological Synapses
2009 Science
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
2020
HIV neuropathy natural history cohort study
2006
IL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection
2009
Multifunctional Human Immunodeficiency Virus (HIV) Gag-Specific CD8+T-Cell Responses in Rectal Mucosa and Peripheral Blood Mononuclear Cells during Chronic HIV Type 1 Infection
2007
HIV Disease Activity as a Modulator of Lipoprotein(a) and Allele-Specific Apolipoprotein(a) Levels
2012
Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
2014